Correlation Between Sarine Technologies and Purple Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sarine Technologies and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarine Technologies and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarine Technologies and Purple Biotech, you can compare the effects of market volatilities on Sarine Technologies and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarine Technologies with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarine Technologies and Purple Biotech.

Diversification Opportunities for Sarine Technologies and Purple Biotech

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Sarine and Purple is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Sarine Technologies and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Sarine Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarine Technologies are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Sarine Technologies i.e., Sarine Technologies and Purple Biotech go up and down completely randomly.

Pair Corralation between Sarine Technologies and Purple Biotech

Assuming the 90 days trading horizon Sarine Technologies is expected to under-perform the Purple Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Sarine Technologies is 7.3 times less risky than Purple Biotech. The stock trades about -0.07 of its potential returns per unit of risk. The Purple Biotech is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  760.00  in Purple Biotech on October 25, 2024 and sell it today you would lose (130.00) from holding Purple Biotech or give up 17.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sarine Technologies  vs.  Purple Biotech

 Performance 
       Timeline  
Sarine Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sarine Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Purple Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Purple Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Purple Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

Sarine Technologies and Purple Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sarine Technologies and Purple Biotech

The main advantage of trading using opposite Sarine Technologies and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarine Technologies position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.
The idea behind Sarine Technologies and Purple Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities